Identification |
Name: | Benzenesulfonamide,5-[(2S)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-, hydrochloride(1:1) |
Synonyms: | Benzenesulfonamide,5-[(2S)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-,monohydrochloride (9CI); Benzenesulfonamide,5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-, monohydrochloride,(S)-; (+)-LY 253352; (+)-YM 617; S-(+)-YM 12617; YM 12617-2 |
CAS: | 106463-19-8 |
Molecular Formula: | C20H28 N2 O5 S . Cl H |
Molecular Weight: | 0 |
InChI: | InChI=1/C20H28N2O5S.ClH/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24;/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24);1H/t15-;/m0./s1 |
Molecular Structure: |
|
Properties |
Usage: | Specific a1-adrenoceptor antagonist. Used in the treatment of benign prostatic hypertrophy |
Safety Data |
|
|